Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
HKD 0.67
(0.0%)
HKD 0.67
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.86 Billion | 2.18 Billion | 3.03 Billion | 2.46 Billion | 2.87 Billion | 2.91 Billion |
| Cost of Revenue | 564.89 Million | 693.6 Million | 607.9 Million | 549.77 Million | 588.98 Million | 538.31 Million |
| Gross Profit | 1.29 Billion | 1.48 Billion | 2.43 Billion | 1.91 Billion | 2.28 Billion | 2.37 Billion |
| Operating Expenses | 1.13 Billion | 3.54 Billion | 1.98 Billion | 1.27 Billion | 4.87 Billion | 525.42 Million |
| Selling, General and Administrative Expenses | 911.21 Million | 1.02 Billion | 1.12 Billion | 858.57 Million | 716.95 Million | 667.22 Million |
| Research and Development Expenses | 592.01 Million | 1.07 Billion | 1.02 Billion | 878.69 Million | 598.95 Million | 480.32 Million |
| Other Expenses | -369.27 Million | 15.77 Million | 24.99 Million | 27.65 Million | 30.32 Million | 31.68 Million |
| Cost and Expenses | 1.69 Billion | 4.23 Billion | 2.58 Billion | 1.82 Billion | 5.46 Billion | 1.06 Billion |
| Operating Income | 161.69 Million | -536.02 Million | 676.19 Million | 485.81 Million | 1.39 Billion | 1.72 Billion |
| Interest Expense | 269.33 Million | 211.17 Million | 117.35 Million | 8.21 Million | 4.87 Million | 6.06 Million |
| Income Tax Expense | 96.42 Million | 196.79 Million | 253.11 Million | 219.04 Million | 290.38 Million | 332.8 Million |
| Earnings before Tax | -161.26 Million | -2.12 Billion | 496.01 Million | 765.84 Million | -2.42 Billion | 2.01 Billion |
| Net Income | -54.01 Million | -1.95 Billion | 416.5 Million | 473.38 Million | -2.7 Billion | 1.61 Billion |
| Earnings Per Share Basic | -0.01 | -0.21 | 0.05 | 0.05 | -0.29 | 0.17 |
| Earnings Per Share Diluted | -0.01 | -0.21 | 0.04 | 0.05 | -0.29 | 0.17 |
| Weighted Average Shares Outstanding | 9.29 Billion | 9.32 Billion | 9.43 Billion | 9.46 Billion | 9.46 Billion | 9.47 Billion |
| Weighted Average Shares Outstanding (Diluted) | 9.29 Billion | 9.32 Billion | 9.48 Billion | 9.46 Billion | 9.46 Billion | 9.47 Billion |
| Gross Margin | 0.70 | 0.68 | 0.80 | 0.78 | 0.80 | 0.82 |
| EBIT Margin | 0.18 | -0.11 | 0.31 | 0.29 | 0.57 | 0.66 |
| Profit Margin | -0.03 | -0.89 | 0.14 | 0.19 | -0.94 | 0.56 |
| EBITDA | 334.31 Million | -1.54 Billion | 931.69 Million | 714.06 Million | -2.06 Billion | 1.91 Billion |
| Earnings Before Tax Margin | 0.09 | -0.25 | 0.22 | 0.20 | 0.48 | 0.59 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 949.69 Million | 1.86 Billion | 804.83 Million | 1.05 Billion | 2.18 Billion | 1.46 Billion |
| Cost of Revenue | 341.18 Million | 564.89 Million | 256.92 Million | 307.97 Million | 693.6 Million | 460.5 Million |
| Gross Profit | 608.51 Million | 1.29 Billion | 547.91 Million | 747.73 Million | 1.48 Billion | 1 Billion |
| Operating Expenses | 499.41 Million | 1.48 Billion | 532.37 Million | 724.69 Million | 3.54 Billion | 922.38 Million |
| Selling, General and Administrative Expenses | 453.8 Million | - | 486.56 Million | 424.65 Million | - | 549.95 Million |
| Research and Development Expenses | 195.58 Million | - | 297.97 Million | 294.03 Million | - | 457.26 Million |
| Other Expenses | -149.98 Million | 50.94 Million | -252.16 Million | - | 15.77 Million | - |
| Cost and Expenses | 840.59 Million | 2.05 Billion | 789.29 Million | 1.03 Billion | 4.23 Billion | 1.38 Billion |
| Operating Income | 109.1 Million | 161.69 Million | 15.53 Million | 60.5 Million | -536.02 Million | 74.65 Million |
| Interest Expense | - | 269.33 Million | - | - | 211.17 Million | - |
| Income Tax Expense | 48.74 Million | 96.42 Million | 10.54 Million | 85.88 Million | 196.79 Million | 151.94 Million |
| Earnings before Tax | -19.21 Million | -161.26 Million | -128.2 Million | -33.05 Million | -2.12 Billion | 56.04 Million |
| Net Income | -33.42 Million | -54.01 Million | -4.37 Million | -49.64 Million | -1.95 Billion | 40.37 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.01 | - | 0.00 |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.01 | - | 0.00 |
| Weighted Average Shares Outstanding | 9.28 Billion | 9.29 Billion | 8.9 Billion | 9.31 Billion | 9.32 Billion | 9.38 Billion |
| Weighted Average Shares Outstanding (Diluted) | 9.28 Billion | 9.29 Billion | 9.28 Billion | 9.31 Billion | 9.32 Billion | 9.32 Billion |
| Gross Margin | 0.64 | 0.70 | 0.68 | 0.71 | 0.68 | 0.69 |
| EBIT Margin | 0.12 | - | -0.16 | 0.16 | - | 0.16 |
| Profit Margin | -0.04 | -0.03 | -0.01 | -0.05 | -0.89 | 0.03 |
| EBITDA | 113.82 Million | - | -128.71 Million | 168.92 Million | - | 237.95 Million |
| Earnings Before Tax Margin | 0.11 | 0.09 | 0.02 | 0.06 | -0.25 | 0.05 |
011700
6690
BANL
IBIDF
GLOBAL
BANT